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Abstract
Background: Although previous studies have helped define the natural history of Duchenne Muscular Dystrophy
(DMD)-associated cardiomyopathy, the myocardial pathobiology associated with functional impairment in DMD is
not yet known.
The objective of this study was to assess the distribution of transverse relaxation time (T2) in the left ventricle (LV)
of DMD patients, and to determine the association of myocardial T2 heterogeneity to the severity of cardiac dys-
function. DMD patients (n = 26) and normal control subjects (n = 13) were studied by Cardiovascular Magnetic
Resonance (CMR). DMD subject data was stratified based on subject age and LV Ejection Fraction (EF) into the fol-
lowing groups: A (<12 years old, n = 12); B (≥12 years old, EF ≤ 55%, n = 8) and C (≥12 years old, EF = 55%, n =
6). Controls were also stratified by age into Groups N1 (<12 years, n = 6) and N2 (>12 years, n = 5). LV mid-slice
circumferential myocardial strain (εcc) was calculated using tagged CMR imaging. T2 maps of the LV were gener-
ated for all subjects using a black blood dual spin echo method at two echo times. The Full Width at Half Maxi-
mum (FWHM) was calculated from a histogram of LV T2 distribution constructed for each subject.
Results: In DMD subject groups, FWHM of the T2 histogram rose progressively with age and decreasing EF (Group
A FWHM= 25.3 ± 3.8 ms; Group B FWHM= 30.9 ± 5.3 ms; Group C FWHM= 33.0 ± 6.4 ms). Further, FWHM was
significantly higher in those with reduced circumferential strain (|εcc| ≤ 12%) (Group B, and C) than those with |εcc|
> 12% (Group A). Group A FWHM was not different from the two normal groups (N1 FWHM = 25.3 ± 3.5 ms; N2
FWHM= 24.0 ± 7.3 ms).
Conclusion: Reduced EF and εcc correlates well with increased T2 heterogeneity quantified by FWHM, indicating
that subclinical functional impairments could be associated with pre-existing abnormalities in tissue structure in
young DMD patients.
Background
Duchenne Muscular Dystrophy (DMD), a lethal X-
linked skeletal and cardiac myopathy, affects 1/3500
males [1]. DMD is caused by mutations in the dystro-
phin gene resulting in greatly reduced or absent dystro-
phin protein, and is characterized by progressive skeletal
muscle weakness, with loss of ambulation typically dur-
ing the second decade [2,3]. A proposed mechanism of
DMD pathogenesis in cardiac muscle is an alteration in
calcium (Ca
2+) homeostasis, whereby micro-tears in the
sarcolemmal membrane and non-specific channel open-
ing events initiate a destructive cascade culminating in
myocyte necrosis and fibrosis [4-6]. Studies have shown
that occult ventricular dysfunction and myocardial fibro-
sis can be diagnosed by Cardiovascular Magnetic Reso-
nance (CMR) in DMD [7,8]. Previously, we found that
peak left ventricular composite myocardial circumferen-
tial strain (εcc) is reduced early in the course of DMD
despite normal ejection fraction (EF), and the strain
values continue to decline with advancing age[9]. While
this and other studies have helped define the natural
history of DMD-associated cardiac dysfunction by char-
acterizing changes in myocardial mechanics, assessment
of the myocardial pathobiology associated with the
regional functional impairment in DMD has not been
described. As such, an index of DMD-associated cardiac
dysfunction that defines the pathobiology of the disease
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of this disease.
A CMR methodology for evaluating in-vivo pathobiol-
ogy has, however, been available for quite some time.
The measure of transverse relaxation time (T2) of tissue
has been well-characterized; T2 weighted MR signal has
been used to detect various pathologies of soft tissues
[10,11]. Factors such as fatty infiltration [12], increased
water content and vasogenic edema[13] are known to
increase T2, while collagen accumulation, as seen in
extracellular matrix fibrosis, is known to decrease T2
[14]. In recent years, T2 weighted imaging, as well as
absolute T2 mapping, has been demonstrated to be
valuable in cardiac imaging of acute myocardial process
such as myocardial infarct [15-17], myocarditis [18,19],
and acute cell mediated transplant rejection[20].
DMD is an example of a progressive disease process
where fibrosis and edema related to inflammation coex-
ist. In a previous study conducted at a magnetic field
strength of 0.5 Tesla, Mavrogeni et al [21] showed that
DMD patients had lower cardiac T2 relaxation time
which progressively decreased with age compared to
control subjects. The same authors recently showed that
with steroid treatment, myocardial T2 increased in older
DMD patients [22]. However, Mavrogeni et al [21] lim-
ited their consideration to the mean T2 value in the
septal region of the heart, forgoing analysis of T2 distri-
bution across multiple regions of the LV. However, we
and others have shown [23,24] that myocardial fibrosis
and regional abnormalities appear heterogeneously, with
initial appearance of abnormalities typically in the LV
free wall.
We thus hypothesized that heterogeneity of T2 across
an entire slice of the heart exist in the early stages of
DMD-associated cardiomyopathy and are associated
with the subclinical functional abnormalities quantified
by myocardial circumferential strain. The purpose of
this study was thus to evaluate the heterogeneity of T2
distribution in the LV in boys with various stages of
DMD.
Methods
Study population
Data were analyzed from records of DMD subjects fol-
lowed at Cincinnati Children’s Hospital Medical Center.
The diagnosis of DMD was confirmed by skeletal mus-
cle biopsy showing absent dystrophin and/or DNA ana-
lysis demonstrating a characteristic dystrophin mutation
in all patients. DMD patients who underwent clinical
CMR between September 2005 and September 2007
were included in this analysis. Additionally, two control
groups of young (N1, n = 8, age 5-10 years) and older
(N2, n = 5, age 32-45 years) normal control males
underwent an identical protocol. EF and |εcc|
measurements were not available in the N2 control
group. The Institutional Review Board at the Cincinnati
Children’s Hospital Medical Center approved the study.
All subjects were > 5 years of age, thereby eliminating
the need for sedation. CMR was performed at our cen-
ter on 97 DMD patients between September 2005 and
September 2007. Data from 71 was excluded due to
absence of T2 images (n= 44), absence of tagged images
(n = 18) or poor tag quality secondary to breathing arti-
fact or patient movement (n = 9).
Subject stratification
The subject data were stratified into 5 groups (two
groups of control subjects: N1(n = 6) and N2(n = 5))
and three groups of DMD patients (A (n = 12), B
(n = 8), and C (n = 6)). Stratification in the control
subjects was based on age. In the DMD subjects strati-
fication was primarily by age and secondarily by LV
Ejection Fraction (EF) (Figure 1). Thus, Group A com-
prised DMD subjects age <12 years with normal EF.
Group B were DMD subjects age ≥12 years with nor-
mal EF. Group C included DMD subjects age ≥12 years
with reduced EF (≤55%). Due to the significant dichot-
omy in ages of the control subjects, they were also
stratified by age into Groups N1 (<12 years) and N2
(>12 years), due to the significant dichotomy in ages of
these subjects.
CMR acquisition
CMR was performed on a Siemens 3-T Trio (Siemens
Medical Solutions, Malvern, Pennsylvania/Erlangen,
Germany) system.
Imaging protocols
Ventricular Volumetry and Global Functional Imaging
Cardiac functional imaging was performed as previously
described [9]. CMR was acquired with retrospective
electrocardiogram (ECG)-gating, segmented steady-state
free precession technique after localized shimming and/
or frequency adjusting. Subjects were breath-held as tol-
erated; for those subjects who could not adequately
breath-hold, a free breathing technique with multiple
signal averaging was used. Standard imaging included a
short-axis stack of cine SSFP images from cardiac base
to apex.
Myocardial Strain Imaging
Tagged cine CMR were acquired in the short axis of the
mid left ventricle at the level of the papillary muscles
with an ECG-triggered segmented k-space fast gradient
echo sequence with spatial modulation of magnetization
in orthogonal planes. Grid tag spacing was 7 to 8 mm.
The scan parameters used were: field of view (30 - 32) ×
(25 - 26) cm
2, slice thickness 6 mm, flip angle 20°, TE/
TR 3 ms/4.2 ms, views/segment 7-9.
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For T2 measurements, spin echo images of the left ven-
tricle in the short axis plane were acquired using a black
blood dual spin echo method. Imaging parameters were:
Slice thickness = 5 mm, in plane resolution = 1.4 mm ×
1.4 mm, echo train length = 5, Echo times: TE1 =6m s ,
TE2 = 34 ms. Data acquisition was done during late dia-
stole by inserting a subject dependent delay.
Data analysis
Ventricular Volumetry and EF
Ventricular volumes, mass, and global function were
assessed via standard planimetry techniques with semi-
automated computer software (QMASS version 6.1.5,
Medis Medical Imaging Systems, Leiden, the Nether-
lands) by expert readers (R.J.F., W.M.G., and K.N.H.).
Myocardial strain analysis
Tagged images were analyzed with the HARmonic Phase
(HARP, Diagnosoft, Palo Alto, California) technique, as
previously described [9]. Based on our experience and
that of others regarding limited reproducibility of the
basal and apical slices, only the midventricular slice was
analyzed [8]. An average of all the regional values/sub-
ject was calculated as a composite whole-slice strain
value εcc, to allow for comparison purposes. All HARP
strain analyses were performed by an experienced reader
(K.N.H.). To assess inter-observer variability of HARP
analysis, a second experienced reader (W.M.G)
performed the same analysis on a subset of DMD sub-
jects (n = 6) and controls (n = 3).
T2 Analysis
T2 values were calculated on a pixel-by-pixel basis
according to the standard description of the signal beha-
vior in spin echo magnetic resonance imaging as:
T2 TE TE S S  () / ( / ) 21 1 2 In (1)
where S1 and S2 are the signal intensity at echo times
TE1 and TE2 respectively. Regions of interests were
manually drawn (J.P.W.) to extract the T2 values. The
LV was defined on the T2 weighted magnitude image
(i.e. at TE = TE2) by manually drawing (J.P.W) the
endo- and epicardial boarders with care taken to avoid
signal from blood. Similarly, lateral wall and septum was
segmented manually as defined by the American Heart
Association 17-segmental model i.e. septum = regions 7
and 8; lateral wall = regions 11 and 12. Using these T2
values, a histogram of LV T2 distribution with bin size
equal to 1 ms was constructed for each subject.
FWHM Calculation
For each histogram, the Full Width at Half Maximum
(FWHM) was calculated after applying box car aver-
aging. The FWHM was defined as the width of the his-
togram at half the maximum height. Additionally, the
mean and the standard deviation of T2 of the entire LV
as well as in the septum and in the lateral wall were
Figure 1 Categorization of the study population. Stratification of Duchenne muscular dystrophy (DMD) patients based on age and ejection
fraction (EF). Normal controls were stratified according to age given their dichotomous distribution.
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surements were done using custom developed software
written in the Interactive Data Language (IDL, Research
Systems Inc., CO, USA).
Statistical analyses
Analyses were performed using SAS® (Version 9.2 Cary,
NC). The General Linear Model procedure was used to
access group differences among the means for FWHM
adjusting for age. Since age was not shown to be signifi-
cant, it was removed from the model. The distribution
of T2 was slightly skewed; therefore the Wilcoxon Rank
sum test was used. All tests were two-sided and p-values
≤0.05 or confidence intervals that did not include zero
were considered statistically significant.
Results
A summery of results is presented in Table 1.
EF and εcc Data
All DMD subjects had abnormal |εcc|<1 6 % ,c o n s i s t e n t
with our prior work [9], despite normal EF in Groups A
and B. As previously found, the mean |εcc|w a ss i g n i f i -
cantly different among the DMD groups and progres-
sively decreased with age and EF. Control subjects in
group N1 had normal EF and normal |εcc| (>16%).
T2 Data
Figure 2 shows the black blood T2 images acquired at
echo times of 6 ms (Figure 2a) and 34 ms (Figure 2b) in
a DMD subject. The T2 maps show heterogeneity of LV
T2 distribution in a DMD patient (Figure 2d) compared
to that of a normal subject (Figure 2c) and were quanti-
fied using T2 histograms (Figure 3). A Wilcoxon Rank
S u mt e s ts h o w e dn os i g n i f i c a n td i f f e r e n c ei nt h em e a n
T 2o ft h ee n t i r eL Va m o n ga l lg r o u p s .S i m i l a r l yn os i g -
nificant difference in the standard deviation of T2 was
found between groups. The age was not a significant
factor in this model. However, the FWHM of the T2
histogram was significantly (p < 0.05) greater in Groups
B (30.9 ± 5.3 ms) and C (33.0 ± 6.4 ms) compared to
that of Group A (25.3 ± 3.8 ms) and the normal Groups
N1 (25.3 ± 3.5 ms) and N2 (24.0 ± 7.3 ms) (Figure 4).
This indicates that significantly greater T2 heterogeneity
in Groups B and C with advanced cardiac dysfunction.
These results also show that DMD patients with normal
EF but impaired circumferential strain (|εcc| ≤ 12%,
Group B) had a significantly greater T2 heterogeneity
than that of DMD patients with normal EF and |εcc|
>12% (Group A).
Among DMD patients with Normal EF (i.e. Groups A
and B), a trend towards increasing FWHM with decreas-
ing mean T2 of the LV (T2mean) was noticed. We char-
acterized this trend by calculating the ratio FWHM/
T2mean for all subjects of groups A and B. FWHM/
T2mean was significantly (p < .0001) higher in group B
(0.54 ± 0.08) compared to Group A (0.42 ± 0.06).
Regression analysis showed moderate association
between FWHM/mean T2 and |εcc|i ng r o u pAa n dB
(Figure 5). (Pearson correlation coefficient r = .51). Age
alone was not found to be a significant factor in predict-
ing T2 heterogeneity.
Results of regional analysis of mean T2, T2 FWHM
and εcc are shown in Table 2. Mean T1 and T2 FWHM
were higher in the septum than in the lateral wall. No
difference in the septum and lateral wall was found in
εcc. Although not statistically significant the lateral wall
T2 FWHM followed the same trend as T2 FWHM of
t h ee n t i r eL V :G r o u pA( 1 9±6m s )<G r o u pB( 2 1±8
ms) < Group C (26 ± 6 ms).
Three investigators blind to the identity of the subjects
independently measured the mean T2 and T2 FWHM of
6 subjects using the custom made software. For each
subject, the mean and the standard deviation of the
independent measurements were calculated. The inter-
observer variability of T2 and T2 FWHM was assessed
as the standard deviation/mean %, averaged among all
the subjects. The mean percentage of standard deviation
among the investigators was 3.2% for meant T2 and
3.1% for T2 FWHM.
Discussion
In this study, we used the Full Width of Half Maximum
(FWHM) of T2 distribution in LV to quantify the
Table 1 Summary of CMR findings between groups. Group values are presented as mean ± standard deviation
Group EF % |Ecc| % Age T2 (ms) FWHM (ms)
A (n = 12) 64 ± 4 14.2 ± 0.8* 10.5 ± 2.6 * 61 ± 9 25.3 ± 3.8
B (n = 8) 60 ± 3 11.0 ± 0.8 †* 17.5 ± 4.6 †* 58 ± 9 30.9 ± 5.3 †*
C (n = 6) 40 ± 11 †‡ 7.7 ± 0.3 †‡* 17.5 ± 6.3 †* 63 ± 6 33.0 ± 6.4 †*
N1 (n = 6) 65 ± 5 20 ± 2.5 7.3 ± 1.6 57 ± 9 25.5 ± 3.5
N2 (n = 5) 41.2 ± 4.2 46 ± 11 24.0 ± 7.3
* The mean is statistically different to that of Group N1 with a p < 0.05
† The mean of Group A is statistically different to that of Group B or C with a p < 0.05
‡ The mean of Group B is statistically different to that of Group C with a p < 0.05
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Page 4 of 8Figure 2 Left Ventricular T2 Maps. Black blood fast spin echo images of the left ventricle at TE = 6 ms (a) and TE= 34 ms (b) in the short axis
view of a DMD subject. The T2 maps of a normal (c) and DMD subjects (d: group A, e: group B and f: group C) show the increasing
heterogeneity of T2 in the LV corresponding to the severity of disease.
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DMD subject groups, FWHM of the T2 histogram rose
progressively with age and decreasing EF. Further,
FWHM was significantly higher in those with reduced
circumferential strain (|εcc| ≤ 12%) (Group B, and C)
than those with |εcc| > 12% (Group A). The myocardial
structural abnormality suggested by the observed trend
is likely due to concomitant presence of micro-fibrosis
(long before it becomes overt enough to be detected
by the myocardial Late Gadolinium Enhancement
(LGE) technique) and myocardial edema. Our results
support the notion that the regional dysfunction
depicted by depressed |εcc| is associated with the ultra-
structural myocardial cell abnormality present in DMD
patients.
T2 is known to increase with intramuscular edema
and inflammation that increases free water content in
tissue [13] whereas fibrosis tend to decrease T2 relaxa-
tion time through increase in the collagen fractional
area [14,25]. Autopsy studies have clearly shown that
fibrosis and intramuscular edema co-exist in the DMD
cardiac muscle [26]. Therefore the spread of T2, quanti-
fied by FWHM rather than the mean T2 is likely to bet-
ter characterize this disease. Furthermore, LGE studies
in muscular dystrophy show that distribution pattern of
late enhancement is patchy and diffused unlike the well
defined sub-endocardial LGE related to coronary terri-
tories found in myocardial infarction [7,24,27-29] sig-
nifying the spatial heterogeneity of the disease. The T2
Figure 3 T2 histograms. Examples of normalized (i.e. area under
curve = 1) T2 histograms of DMD (Group A, B and C) and Normal
control (N1) subjects show that DMD patients with normal EF but
impaired εcc has higher heterogeneity in T2 compared to other
groups.
Figure 4 Graphs of FWHM/Strata. The FWHM of the DMD groups
B (age >12 yrs, EF ≤ 55%, |εcc| < 12%) and C (age >12 yrs EF =
55%, |εcc| < 12%) were significantly higher than all other groups
including group A (age <12 yrs EF > 55%, |εcc| > 12%) indicating
increased heterogeneity in the T2 distribution in DMD with
impaired regional and global function.
Figure 5 Regression of FWHM/T2mean vs εcc. Regression analysis
show a moderate association between FWHM/T2mean and εcc in
group A and B (Pearson correlation coefficient r = .51) suggesting
the presence of microscopic fibrosis long before it becomes overt
enough to be detected by the LGE technique.
Table 2 Regional CMR findings between groups. Group
values are presented as mean ± standard deviation
Mean T2 (ms) FWHM T2 (ms) |Ecc| (%)
Septum Free Wall Septum Free Wall Septum Free Wall
A 66 ± 10 55 ± 12* 27 ± 8 19 ± 6* 14.8 ± 0.7 14.7 ± 0.8
B 63 ± 13 53 ± 6 27 ± 10 21 ± 8 11.2 ± 1.5 12.0 ± 0.9
C 63 ± 13 66 ± 12 22 ± 7 26 ± 6 7.0 ± 0.7 7.7 ± 0.9
N1 67 ± 20 48 ± 8* 22 ± 8 20 ± 7 16.8 ± 1.0 17.6 ± 1.1
N2 59 ± 24 43 ± 9 23 ± 16 19 ± 10 - -
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pathologic heterogeneity of the DMD tissue.
Unlike the FWHM, the standard deviation of T2, cal-
culated assuming that T2 is normally (Gaussian) distrib-
uted within the LV, was not significantly different
between groups. This is not surprising since the histo-
grams of T2, as seen in Figure 3, deviate significantly
from that of a normal distribution. The Skewness, a
measure of deviation from the normal distribution, was
> 1.2 for all subjects confirmed this observation. There-
fore, we conclude that the standard deviation of T2 did
not accurately quantify the heterogeneity of T2 in the
LV and consequently failed to distinguish DMD and
normal subjects.
The mean myocardial T2 of the normal subjects (both
N1 and N2 combined) in our study was 52 ± 11 ms
which is same as that found by Giri et al (52 ± 3 ms)
[30]. Regional analysis of T2 revealed that mean T2 was
consistently lower in the lateral wall than in the septum
i na l lg r o u p s .T h i sm a yb ed u et ot h ei n c r e a s e dm a g -
netic field inhomogeneity at the lateral wall due to the
air-tissue interface. Increased B1 and B0 inhomogene-
ities at 3 Tesla pose significant challenges to uniform
inversion of magnetization across the imaged volume
affecting the accuracy of T2 calculations. As a routine
practice 3D volume shimming should be employed to
improve B0 homogeneity at 3 Tesla. Adiabatic radio fre-
quency pulses, characterized by simultaneous modula-
tion of amplitude and frequency or phase have been
successful in mitigating B1 and B0 inhomogeneities
[31-33]. These adiabatic pulses could be used in combi-
nation with T2 preparation schemes to generate differ-
ently weighted T2 images which then could be used to
quantify T2.
Study limitations
We used a turbo spin echo method with two acquisi-
tions (echoes) to calculate T2. The dual echo method
has been successfully used by others in cardiac and
brain imaging applications in the past [13,30,34]. While
it allows image acquisition to be performed during a
single breath hold, it limits the accuracy of the curve fit-
ting. However, the alternative technique of acquiring
multiple echo times requires scanning to be performed
during free breathing leading to volume averaging of the
signal that could also affect the accuracy of the T2. Giri
et al[30] recently demonstrated the superiority of T2
prepared dual echo steady state free precision (SSFP)
method for measuring cardiac T2 at 1.5 Tesla. With
care taken to circumvent the effects of B0 inhomogene-
ity, this method could be ideally suited for cardiac T2
measurement in the DMD at 3Tesla.
Although significant differences in |εcc|a n dFWHM
were demonstrated between young DMD patients with
normal EF and older patients with reduced EF, this is a
cross-sectional and not a serial study. Accordingly,
repeat serial examinations would provide a more robust
analysis of longitudinal |εcc|a n dFWHM in this patient
population. In the current study, only the midventricular
slice was analyzed secondary to our experience of lim-
ited reproducibility of the basal and apical slices.
Conclusions
The increased FWHM in T2 points to an underlying
pathobiology that is both microscopic and widely dis-
tributed within the myocardium. Unlike gross myocar-
dial changes that arise in the later stages of the disease,
these early abnormalities are not likely to be detected by
T2 weighted imaging or LGE. Thus, T2 heterogeneity
quantified by FWHM could provide an early surrogate
marker for pathobiology in DMD patients to monitor
activity of disease as well as to assess efficacy of phar-
macological interventions.
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